Document:

Exhibit 10(b)

  

  

  POWER OF ATTORNEY

  

  

  We, the undersigned directors and/or officers of The Lincoln National Life Insurance Company, hereby constitute and appoint Delson R. Campbell, Scott C. Durocher, Kimberly A. Genovese, Daniel P. Herr, Donald E. Keller, Michelle Grindle,  Jeffrey L. Smith, Jassmin McIver-Jones, Carolyn Augur and John D. Weber,  individually, our true and lawful
    attorneys-in-fact, with full power to each of them to sign for us, in our names and in the capacities indicated below, any Registration Statements and any and all amendments to Registration Statements; including exhibits, or other documents filed on
    Forms N-6, N-4 or S-3 or any successors or amendments to these Forms, filed with the Securities and Exchange Commission, under the Securities Act of 1933 and/or Securities Act of 1940, on behalf of the Company in its own name or in the name of one of
    its Separate Accounts, hereby ratifying and confirming our signatures as they may be signed by any of our attorneys-in-fact to any such amendments to said Registration Statements as follows:

  

  

  Variable Life Insurance Separate Accounts:

  

  

  
    
      

  

  	
          Account

        	
          Product name

        
	
          Lincoln Life Flexible Premium Variable Life Account D (811-04592)

        	
          Variable Universal Life Leadership Series

        
	
          Lincoln Life Flexible Premium Variable Life Account F (811-05164)

        	
          American Legacy Life

          American Legacy Estate Builder

        
	
          Lincoln Life Flexible Premium Variable Life Account G (811-05585)

        	
          VUL-III

        
	
          Lincoln Life Flexible Premium Variable Life Account J (811-08410)

        	
          American Legacy Variable Life

        
	
          Lincoln Life Flexible Premium Variable Life Account K (811-08412)

        	
          Multi Fund Variable Life

        
	
          Lincoln Life Flexible Premium Variable Life Account M (811-08557)

        	
          VULdb / VULdb ES

          VULdb-II ES

          VUL-I / VULcv

          VULcv-II / VULcvII ES / VUL Flex

          VULcv-III ES

          MoneyGuard VUL

          VULone ES / VULone 2005 ES

          Momentum VULone / Momentum VULone 2005

          VULcv-IV ES

          VULdb-IV ES

          Momentum VULone 2007

          VULone 2007

          AssetEdge VUL

          AssetEdge VUL2015/AssetEdge Exec VUL 2015

          VULone2012

          VULone2014

          InReach VULone2014

          VULone2019

          AssetEdge VUL2019/AssetEdge Exec VUL 2019

          AssetEdge VUL2019-2/AssetEdge Exec VUL 2019-2

          AssetEdge VUL2020/AssetEdge Exec VUL 2020

        
	
          Lincoln Life Flexible Premium Variable Life Account R (811-08579)

        	
          SVUL / SVUL-I

          SVUL-II / SVUL-II ES

          SVUL-III ES

          SVUL-IV ES / PreservationEdge SVUL

          SVULone ES

          Momentum SVULone

          SVULone 2007 ES

          Momentum SVULone 2007

          SVULone2013

          SVULone2016

          SVULone2019

        
	
          Lincoln Life Flexible Premium Variable Life Account S (811-09241)

        	
          CVUL / CVUL Series III / CVUL Series III ES

          LCV4 ES

          LCV5 ES / LCC VUL

          Lincoln Corporate Executive VUL

        
	
          Lincoln Life Flexible Premium Variable Life Account Y (811-21028)

        	
          American Legacy VULcv-III

          American Legacy VULdb-II

          American Legacy SVUL-II

          American Legacy SVUL-III

          American Legacy VULcv-IV

          American Legacy VULdb-IV

          American Legacy SVUL-IV/PreservationEdge SVUL

          American Legacy AssetEdge

        

  

  

  

  

  Variable Annuity Separate Accounts:

  

  

  	
          Account

        	
          Product name

        
	
          Lincoln National Variable Annuity Account C (811-03214)

        	
          Multi-Fund

          Multi-Fund Select

          Multi-Fund 5 Retirement Annuity

        
	
          Lincoln National Variable Annuity Account E (811-04882)

        	
          The American Legacy

        
	
          Lincoln National Variable Annuity Account H (811-05721)

        	
          American Legacy II

          American Legacy III

          American Legacy III B Class

          American Legacy III C Share

          American Legacy III Plus

          American Legacy III View

          American Legacy Design

          American Legacy Signature

          American Legacy Fusion

          American Legacy Series

          American Legacy Advisory

          American Legacy Target Date Income B Share

          American Legacy Target Date Income Advisory

          Shareholder’s Advantage

          Shareholder’s Advantage A Class

          Shareholder’s Advantage purchased on and after May 21, 2018

        
	
          Lincoln National Variable Annuity Account L (811-07645)

        	
          Group Variable Annuity

          Secured Retirement Income Version 1

          Secured Retirement Income Version 2

          Secured Retirement Income Version 3

          Secured Retirement Income Version 4

          Retirement Income Rollover Version 1

          Retirement Income Rollover Version 2

          Retirement Income Rollover Version 3

          Retirement Income Rollover Version 4

        
	 	 
	
          Lincoln Life Variable Annuity Account N (811-08517)

        	
          ChoicePlus Assurance (A Share)

          ChoicePlus Assurance (A Class)

          ChoicePlus Assurance (B Share)

          ChoicePlus Assurance (B Class)

          ChoicePlus Assurance (C Share)

          ChoicePlus Assurance (L Share)

          ChoicePlus Assurance (Bonus)

          Choice Plus

          Choice Plus II

          ChoicePlus Access

          ChoicePlus II Access

          ChoicePlus Bonus

          ChoicePlus II Bonus

        
	 	
          ChoicePlus II Advance

          ChoicePlus Design

          ChoicePlus Signature

          ChoicePlus Rollover

          ChoicePlus Fusion

          ChoicePlus Series

          ChoicePlus Prime

          ChoicePlus Advisory

          ChoicePlus Select B-Share

          InvestmentSolutions

          InvestmentSolutions RIA

          Lincoln Investor Advantage

          Lincoln Invester Advantage 2018

          Lincoln Investor Advantage Fee-Based

          Lincoln Investor Advantage RIA

          Lincoln Investor Advantage Advisory

          Lincoln Investor Advantage RIA Class

          Lincoln Investor Advantage Advisory Choice

          Lincoln Level Advantage B Share Indexed Variable Annuity

          Lincoln Level Advantage Advisory Indexed Variable Annuity

          Lincoln Level Advantage B Class Indexed Variable Annuity

          Lincoln Level Advantage Advisory Class Indexed Variable Annuity

          Lincoln Level Advantage Fee-Based Indexed Variable Annuity

          Lincoln Level Advantage Select B-Share Indexed Variable Annuity

          Lincoln Level Advantage Design B-Share Indexed Variable Annuity

          Lincoln Level Advantage Design Advisory Indexed Variable Annuity

          Core Income

        
	
          Lincoln Life Variable Annuity Account Q (811-08569)

        	
          Multi-Fund Group

        
	
          Lincoln Life S-3 Filing

        	
          Lincoln Level Advantage B Share Indexed Variable Annuity

          Lincoln Level Advantage Advisory Indexed Variable Annuity

          Lincoln Level Advantage B Class Indexed Variable Annuity

          Lincoln Level Advantage Advisory Class Indexed Variable Annuity

          Lincoln Level Advantage Fee-Based Indexed Variable Annuity

          Lincoln Level Advantage Select B Share Indexed Variable Annuity

          Lincoln Level Advantage Design B-Share Indexed Variable Annuity

          Lincoln Level Advantage Design Advisory Indexed Variable Annuity

        

  

  

  

  

  Except as otherwise specifically provided herein, the power-of-attorney granted herein shall not in any manner revoke in whole or in part any power-of-attorney that
    each person whose signature appears below has previously executed.  This power-of-attorney shall not be revoked by any subsequent power-of-attorney each person whose signature appears below may execute, unless such subsequent power specifically refers
    to this power-of-attorney or specifically states that the instrument is intended to revoke all prior general powers-of-attorney or all prior powers-of-attorney.

  

  

  This Power-of-Attorney may be executed in separate counterparts each of which when executed and delivered shall be an original; but all such counterparts shall
    together constitute one and the same instrument.  Each counterpart may consist of a number of copies, each signed by less than all, but together signed by all, of the undersigned.

  

  

  

  

  

  

  Signature                                                                                    Title

  

  

  /s/Dennis R. Glass

  	______________________________	
          President, Chairman and Director

        

  Dennis R. Glass

  

  

  /s/Ellen G. Cooper

  	_____________________________	
          Executive Vice President, Chief Investment Officer

        

  Ellen G. Cooper                                                                                                  and Director

  

  

  /s/Randal J. Freitag

  	_____________________________	
          Executive Vice President; Chief Financial Officer and Director

        

  Randal J. Freitag

  

  

  /s/Christine A. Janofsky

  	_____________________________	
          Senior Vice President and Controller

        

  Christine A. Janofsky

  

  

  /s/Leon E. Roday

  	_____________________________	
          Executive Vice President, General Counsel and Director

        

  Leon E. Roday

  

  

  /s/Wilford H. Fuller

  	_____________________________	
          Executive Vice President and Director

        

  Wilford H. Fuller

  

  

  /s/Keith J. Ryan

  ______________________________                                       Vice President and Director

  Keith J. Ryan

  

  

  

  

  We, Delson R. Campbell, Scott C. Durocher, Kimberly A. Genovese, Daniel P. Herr, Donald E. Keller, Michelle Grindle, Jeffrey L. Smith, Jassmin McIver-Jones,
    Carolyn Augur and John D. Weber, have read the foregoing Power of Attorney.  We are the person(s) identified therein as agent(s) for the principal named therein.  We acknowledge our legal responsibilities.

  

  

  	
          /s/Delson R. Campbell                                                      

          Delson R. Campbell

           

        	
          /s/Scott C. Durocher  

          Scott C. Durocher

        
	
          /s/Kimberly A. Genovese                                                      

          Kimberly A. Genovese

           

        	
          /s/Daniel P. Herr                                                      

          Daniel P. Herr

        
	
          /s/Donald E. Keller                                                      

          Donald E. Keller

           

        	
          /s/Michelle Grindle                                                      

          Michelle Grindle

        
	
          /s/Jeffrey L. Smith                                                      

          Jeffrey L. Smith

           

        	
          /s/John D. Weber                                                      

          John D. Weber

        
	
          /s/Jassmin McIver-Jones                                                      

          Jassmin McIver-Jones

        	
          /s/Carolyn Augur                                                      

          Carolyn Augur

        

  

  

  

  

  

  

  

  

  

  

  Version dated: 5/2020curr_ex101.htm

  EXHIBIT 10.1

   
	  
	 Cure Pharmaceutical
1620 Beacon Place
Oxnard, CA 93033
Phone: 1-805-824-0410
Fax: 1-805-487-7163

  May 6, 2020
  
DELIVERED VIA EMAIL
 
Jessica Rousset 
2137 Fargo Street
Los Angeles, CA 90039
 
	 Re: 
	Separation Agreement 

      
Dear Jessica:
 
This Separation Agreement (“Agreement”) confirms the mutual agreement we have reached concerning your separation from employment with CURE Pharmaceutical Corporation (the “Company”). For purposes of this Agreement, you are referred to as “Employee” or “you”. Subject to your return of a signed copy of this Agreement to the undersigned, the Company will provide you certain severance payments and benefits as listed below:
 
1. Termination of Employment. In consideration of the mutual promises and covenants contained in this Separation Agreement, Employer's employment of Employee is terminated by Employee's resignation effective as of May 8, 2020.
 
a. On May 8, 2020 you will be issued a final paycheck that will include payment for services rendered through May 8, 2020 plus payment for all accrued but unused vacation benefits and floating holiday benefits. Any and all claims for business expense reimbursement must be submitted by May 8, 2020.
 
b. Information concerning any right that you may have to continue your participation in the Company's group health insurance plan under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) will be provided under separate cover. You will also receive information concerning your 401(k) distribution options and cash-out options associated with the Executive Profit Interest Program. Likewise, information about California's Unemployment Insurance Benefit programs will be furnished.
 
	 
	1
	

	 

     
2. Severance Payment and Benefits.
 
Provided that you fully discharge your obligations under the terms of this Agreement:
 
a. The Company shall pay to you the gross sum of ninety-three thousand four hundred sixty-one dollars and fifty-four cents ($93,461.54). Said sum, which represents a severance benefit equal to six (6) months' pay plus one week at your present base rate of pay, shall be paid in equal installments over a six - month period beginning no later than the payroll date for the first full payroll period following the Effective Date, as defined in Section 21 of this Agreement. All such payments shall be subject to deductions and withholding required by law or authorized by you. Such installment payments shall be remitted via direct deposit or mailed to your home on the dates that correspond to the Company's regular payroll dates.
 
b. If you timely elect, in the manner required by law, to continue your participation in the Company's group health plans through COBRA continuation, and provided that you remain eligible for such coverage, the Company shall pay premiums and any administrative fee required to maintain such continuation coverage for you (at your current level) for the period beginning June 1, 2020, until and including November 30, 2020. The Company shall make such premium payments directly to the insurance provider(s). Thereafter, you may continue coverage for yourself and your beneficiaries at your own expense, to the extent you and they remain eligible for such coverage.
 
c. As of May 8, 2020, you will have vested in 217,500 out of a total of 290,000 shares subject to the incentive stock option granted to you on April 6, 2018 and 30,000 out of a total of 60,000 shares subject to the incentive stock option granted to you on May 7, 2018. Under their terms, the vesting of your stock options will cease as of May 8, 2020. However, upon the Effective Date, the Company will accelerate the vesting of your stock options, such that they will become vested as of the Effective Date for the additional number of shares that would have vested in accordance with their terms had your employment continued through November 15, 2020. Accordingly, on the Effective Date, you will be vested in an additional 36,250 shares under the April 6, 2018 option and an additional 7,500 shares under the May 7, 2018 option. Further, as of the Effective Date, the Company will extend the date through which your unexercised and exercisable vested shares may be exercised to May 8, 2021 with respect to 133,750 under the April 6, 2018 option and all shares under the May 7, 2018 option. Under the April 6, 2018 option, 120,000 of the unexercised and exercisable vested shares will remain exercisable only until August 8, 2020. You acknowledge that if your stock options are in-the-money as of the date of this Agreement, the extension of the exercise period will cause your exercise of the portions of the options as to which the exercise period was so extended to be treated as the exercise of nonqualified stock options and not the exercise of incentive stock option s. Accordingly, the excess of the fair market value of such shares you acquire on their exercise date over the exercise price will be ordinary income subject to applicable income and employment tax withholding , for which you must make provision in accordance with the terms of your stock option agreement.
 
	 
	2
	

	 

  
3. Release of Claims
 
In consideration of the payments and premium payments described in Section 2, above, you irrevocably and unconditionally release and forever discharge the Company, all affiliated and related entities, their respective predecessors, successors, and assigns, and the current and former trustees, officers, employees, attorneys, and agents of each of the foregoing in their official and personal capacities (all of whom are expressly deemed third-party beneficiaries hereof and collectively referred to as the “Company”) from any and all claims, grievances, penalties, and other legal responsibilities of any form whatsoever (hereinafter “Claims”), whether known or unknown, arising from any cause whatsoever prior to the date on which you sign this Agreement, including, without limitation, any Claims that the Company discriminated against you on any basis prohibited by federal, state, or local statute, regulation, ordinance, order, or law (including, without limitation, any claim for age discrimination under the Federal Age Discrimination in Employment Act, 29 U.S.C. §§ 621, et seq.), breached any contract or promise, express or implied, or violated any federal, state, or local statute, ordinance, order, or law, or any other Claims based upon, relating to, or arising out of your employment relationship with the Company and the termination of that relationship. The foregoing notwithstanding, nothing contained herein shall constitute a release of any Claims that cannot be waived as a matter of law. Nor shall anything contained herein be construed to prohibit you from filing a complaint with, or participating in any investigation or proceeding conducted by, a federal, state, or local administrative agency (including the Equal Employment Opportunity Commission or National Labor Relations Boar d), although you do waive any right to monetary or other individual relief related to any such administrative complaint or proceeding.
 
4. Release of Unknown Claims
 
You acknowledge that you have been made aware of California Civil Code section 1542, which provides,
 
A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the debtor or released party .
 
You agree to hereby waive and release any rights that you may have under California Civil Code section 1542, or under any other law or statute of similar effect in any jurisdiction, to the full extent that all such rights may lawfully be waived.
 
5. Return of Property
 
You acknowledge that other than the property to which title has been transferred to you, you have returned all Company property, including, without limitation, keys and access cards, credit cards, files, and any documents (including media containing computerized data and any copies made of any digital data or software) which contain information concerning the Company, Company-affiliated or -related entities, or the business or existing or prospective business relationships of any of them. You further acknowledge and agree that if, after executing this Agreement, you discover that you have any such property in your possession, you shall return it to the Company immediately.
 
	 
	3
	

	 

  
6. Non-Disparagement
 
You agree that you will not, at any time, make publish, or communicate to any person or entity or in any public forum any defamatory or disparaging remarks, comments, or statements concerning the Company, any Company-affiliated or -related entities, or any of the current or former directors, officers, or employees of any of them.
 
7. Confidential Information
 
You understand and agree that you have been employed in a position of confidence and trust and have had access to and became acquainted with information concerning the operation of the Company and its related entities, including, without limitation, financial, personnel, marketing, planning, and other proprietary information that is owned by the Company and regularly used in the operation of the Company's business, and which constitutes Company trade secrets and confidential information (“Confidential Information”). You agree not to disclose the Confidential Information to anyone and not to use the Confidential Information for any purpose whatsoever, except to the extent that such information is generally known in the industry or hereafter becomes so known without default under this Agreement.
 
8. Confidentiality
 
You agree that the existence, terms, and conditions of this Agreement are strictly confidential and, with the exception of your legal and/or financial advisor, immediate family, or as required by applicable law, shall not be disclosed, discussed, or revealed to any other person, entity, or organization, whether within or outside the Company, without prior written approval by me or my designee. Disclosure of the existence or the terms and conditions of this Agreement to your immediate family may only occur if such person first agrees to be bound by this confidentiality provision. Unless required by law, Company shall hold the existence, terms, and conditions of this Agreement in strict confidence. If the existence, terms, and conditions of this Agreement are disclosed by Company in accordance with this Section 8, Employee's obligations of confidentiality regarding the same shall cease.
 
9. Protected Rights
 
You acknowledge and understand that nothing in Sections 6, 7, or 8 of this Agreement, or the Agreement as a whole, shall in any way restrict or impede you from exercising protected rights to the extent that such rights cannot be waived by agreement, or from complying with any applicable law or regulation or a valid order of a court of competent jurisdiction or an authorized government agency, provided that such compliance does not exceed that required by the law, regulation, or order, or to testify truthfully in an administrative, legislative, or judicial proceeding, including with respect to matters concerning alleged criminal conduct or sexual harassment.
 
	 
	4
	

	 

  
10. No Transfer/Assignment
 
You represent and warrant that you have not transferred or assigned to any person or entity any Claims released herein.
 
11. Bound Parties
 
This Agreement shall be binding upon and shall inure to the benefit of your heirs, administrators, and representatives, including but not limited to attorneys, executors, successors, and assigns.
 
12. Legal Representation
 
This Agreement is a legally binding document, and your signature will commit you to the Agreement's terms. You acknowledge that you have been advised to discuss all aspects of this Agreement with an attorney, that you have carefully read and fully understand all of the provisions of this Agreement, and that you are voluntarily entering into this Agreement.
 
13. Absence of Reliance
 
In signing this Agreement, you are not relying upon any promises or representations made by anyone at or on behalf of the Company, except as expressly set forth in this Agreement.
 
14. No Admission of Liability
 
You and the Company agree that this Agreement, and the performance of acts required by it, do not constitute an admission of liability or wrongdoing on the part of anyone and will not be construed for any purpose as an admission of liability or wrongdoing by you or the Company.
 
15. Enforceability
 
If any portion or provision of this Agreement (including, without limitation, any portion or provision of any section of this Agreement) shall, to any extent, be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which the portion or provision is so declared illegal or unenforceable, shall not be affected by such declaration, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.
 
16. Waiver
 
No waiver of any provision of this Agreement shall be effective unless made in writing and signed by the waiving party. The failure of any party to require the performance of any term or obligation of this Agreement, or the waiver by any party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.
 
	 
	5
	

	 

  
17. Governing Law; Interpretation
 
This Agreement shall be interpreted and enforced under the laws of the State of California without regard to conflict of law principles. In the event of any dispute, this Agreement is intended by the parties to be construed as a whole, to be interpreted in accordance with the Agreement's fair meaning, and not to be construed strictly for or against either you or the Company or the “drafter” of all or any portion of this Agreement.
 
18. Arbitration
 
Any dispute between you and the Company concerning the enforcement, performance, interpretation, effect, or alleged violation of this Agreement shall be determined by binding arbitration administered by JAMS pursuant to JAMS' Employment Arbitration Rules and Procedures (http://www.jamsadr.com/rules-employment-arbitration/) and Policy on Employment Arbitration Standards of Minimum Fairness (http://www.jamsadr.com/employment-minimum-standards/) then in effect. You and the Company understand and agree that, unless otherwise prohibited by law, this arbitration procedure shall be the exclusive means of redress for any controversy or claim relating to or arising from your employment with the Company, including disputes over rights provided by federal, state , or local statutes, regulations, ordinances, and common law, including all laws that prohibit discrimination based on a protected classification, and further understand and agree that you and the Company are expressly waiving the right to a trial by jury with respect to any such controversy or claim. The arbitration shall take place in the County of Los Angeles, California, before an experienced employment arbitrator licensed to practice law in the State of California. You and the Company may be represented by counsel and shall be entitled to conduct discovery as provided by California Code of Civil Procedure section 1283.05. To the extent permitted by law, all fees of the arbitrator and the arbitration forum costs shall be split equally between the parties. The arbitrator shall have no power to alter, modify, ignore, or otherwise deviate from the express terms of this letter and Agreement. Judgment on the award that the arbitrator renders may be entered in any court having jurisdiction over the parties.
 
20. Entire Agreement
 
This Agreement constitutes the entire agreement between you and the Company with respect to the subject matter hereof. This Agreement supersedes any previous agreements or understandings, either oral or in writing, between you and the Company. Any oral representations or modifications concerning this Agreement shall be of no force or effect. This Agreement can be modified only in the form of a writing signed by both parties hereto.
 
21. Time for Consideration; Effective Date
 
You have been provided with more than twenty-one (21) days to consider the terms of this Agreement before signing it. You have the right to revoke this Agreement at any time within the seven (7)-day period following the date on which you sign the Agreement (the “Revocation Period”), by delivering written notice of such revocation to me, at or before the expiration of the Revocation Peri od. You understand that this Agreement shall not become effective or enforceable until the aforementioned Revocation Period has expired without you having revoked this Agreement, and that if you do not revoke this Agreement, it shall become effective on the day following the last day of the Revocation Period (the “Effective Date”).
 
	 
	6
	

	 

   
Should you have any questions concerning the foregoing, please feel free to contact me. 
 
Very truly yours,
 
CURE Pharmaceutical Corporation
 
 
/s/ Robert Davidson                                                                  
By: Robert Davidson
Chief Executive Officer
 
Agreed this 8th day of May, 2020
 
 
/s/ Jessica Rousset                                                                   
Jessica Rousset
	 
	7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}]]